ConductScience.org, home

Paper374401

Clozapine versus chlorpromazine for the treatment of schizophrenia: preliminary results from a double-blind study.

Gelenberg AJ and 1 other. J Clin Psychiatry, 1979. Cited by 73 papers, by iCite.

Cite this record

ConductScience Library. Clozapine versus chlorpromazine for the treatment of schizophrenia: preliminary results from a double-blind study. Papers, record 374401. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/374401

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Clozapine versus chlorpromazine for the treatment of schizophrenia: preliminary results from a double-blind study.
PubMed
Journal
J Clin Psychiatry
PubMed
Year
1979
PubMed
Publication types
Clinical Trial, Comparative Study, Controlled Clinical Trial, Journal Article
PubMed
Citations, by iCite
73
iCite
Relative citation ratio, by iCite
3.55
iCite
Revised in PubMed
2013-11-21
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Gelenberg AJA J
2Doller JCJ C

Source PubMed

Download CSV of authors

Topics15

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
ChlorpromazineMajor topic
ClozapineMajor topic
DibenzazepinesMajor topic
SchizophreniaMajor topic
Adult
Aged
Clinical Trials as Topic
Double-Blind Method
Drug Administration Schedule
Dyskinesia, Drug-Induced
Female
Humans
Male
Middle Aged
Psychiatric Status Rating Scales

Source PubMed

Download CSV of topics

Cited by13

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 73 citations.

PMIDTitleJournalYearIn PapersSource
31766049Heterogeneity and efficacy of antipsychotic treatment for schizophrenia with or without treatment resistance: a meta-analysis.Neuropsychopharmacology2020https://conductscience.org/library/papers/31766049PubMed
30218445Clozapine as a first- or second-line treatment in schizophrenia: a systematic review and meta-analysis.Acta Psychiatr Scand2018https://conductscience.org/library/papers/30218445PubMed
25321611Placebo response in antipsychotic clinical trials: a meta-analysis.JAMA Psychiatry2014https://conductscience.org/library/papers/25321611PubMed
23738205Comparative evaluation of forced swim test and tail suspension test as models of negative symptom of schizophrenia in rodents.ISRN Psychiatry2012https://conductscience.org/library/papers/23738205PubMed
20209133Changes in clinical trials methodology over time: a systematic review of six decades of research in psychopharmacology.PLoS One2010https://conductscience.org/library/papers/20209133PubMed
19160174Clozapine versus typical neuroleptic medication for schizophrenia.Cochrane Database Syst Rev2009https://conductscience.org/library/papers/19160174PubMed
18615139Modulation of midbrain dopamine neurotransmission by serotonin, a versatile interaction between neurotransmitters and significance for antipsychotic drug action.Curr Neuropharmacol2006https://conductscience.org/library/papers/18615139PubMed
8581295Enhancement of immobility in a forced swimming test by subacute or repeated treatment with phencyclidine: a new model of schizophrenia.Br J Pharmacol1995https://conductscience.org/library/papers/8581295PubMed
7121608Effects of clozapine in a selective muscarinic bioassay and on single cells of the rat hippocampus.Naunyn Schmiedebergs Arch Pharmacol1982https://conductscience.org/library/papers/7121608PubMed
6149590Neuroleptic-induced striatal dopamine receptor supersensitivity in mice: relationship to dose and drug.Psychopharmacology (Berl)1984https://conductscience.org/library/papers/6149590PubMed
2870130Effect of neuroleptics and of potential new antipsychotic agents (MJ 13859-1 and MJ 13980-1) on a monkey model of tardive dyskinesia.J Neural Transm1986https://conductscience.org/library/papers/2870130PubMed
2813668Efficacy and adverse effects of clozapine in the treatment of schizophrenia and tardive dyskinesia--a retrospective study of 387 patients.Psychopharmacology (Berl)1989https://conductscience.org/library/papers/2813668PubMed
2506596Differences in the time course of dopaminergic supersensitivity following chronic administration of haloperidol, molindone, or sulpiride.Psychopharmacology (Berl)1989https://conductscience.org/library/papers/2506596PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/374401

GET https://conductscience.org/api/papers/v1/374401/authors